These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7564782)

  • 1. Tackling liver cancer with interferon.
    Schluger LK; Bodenheimer H
    Lancet; 1995 Oct; 346(8982):1049-50. PubMed ID: 7564782
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy for chronic hepatitis C: interferon and ribavirin.
    Christie JM; Chapman RW
    Hosp Med; 1999 May; 60(5):357-61. PubMed ID: 10396412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin.
    Götz G; Schön MR; Haefker A; Neuhaus R; Berg T; Hopf U; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2104-6. PubMed ID: 9723407
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatments for hepatitis virus C infections].
    Pol S; Fontaine H; Vallet-Pichard A
    Gastroenterol Clin Biol; 2001 Mar; 25(3):287-307. PubMed ID: 11395676
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries for patients. Long-term effects of antiviral treatment for hepatitis C.
    Ann Intern Med; 2005 Jan; 142(2):I51. PubMed ID: 15657153
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recurrence of hepatocellular carcinoma and its treatment].
    Komechi H; Tutui H; Aramaki T; Ohoya T; Kumazaki T
    Nihon Ika Daigaku Zasshi; 1998 Feb; 65(1):69-72. PubMed ID: 9513372
    [No Abstract]   [Full Text] [Related]  

  • 7. Occurrence of hepatocellular carcinoma 13 years after successful antiviral treatment for HCV infection.
    Puoti C; Lanzetta G; Scotti E
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):408-9. PubMed ID: 27689211
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon and hepatocellular carcinoma.
    Andreone P; Cursaro C; Gramenzi A; Trevisani F; Gasbarrini G; Bernardi M
    Lancet; 1996 Jan; 347(8995):195. PubMed ID: 8544566
    [No Abstract]   [Full Text] [Related]  

  • 9. [A small-sized hepatocellular carcinoma].
    Barbare JC
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B159-64. PubMed ID: 12843953
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon: benefit beyond hepatitis therapy?
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2001 Dec; 96(12):3435-6. PubMed ID: 11774964
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis.
    Tamai H; Mori Y; Shingaki N; Shimizu R; Nuta J; Moribata K; Maeda Y; Muraki Y; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Takifuji K; Yamaue H; Ichinose M
    Hepatol Int; 2015 Jan; 9(1):67-75. PubMed ID: 25788381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C].
    Pache I; Gonvers JJ
    Rev Med Suisse Romande; 2002 Oct; 122(10):507-12. PubMed ID: 12494784
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.
    Nishiguchi S; Kuroki T; Nakatani S; Morimoto H; Takeda T; Nakajima S; Shiomi S; Seki S; Kobayashi K; Otani S
    Lancet; 1995 Oct; 346(8982):1051-5. PubMed ID: 7564784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008].
    Pár A; Pár G
    Orv Hetil; 2008 Jul; 149(28):1329-32. PubMed ID: 18617461
    [No Abstract]   [Full Text] [Related]  

  • 15. Summaries for patients. Does exposure to hepatitis B virus increase the risk for liver cancer in patients with hepatitis C infection?
    Ann Intern Med; 2007 May; 146(9):I59. PubMed ID: 17470828
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in liver disease. Highlights from the 51st Annual Meeting of the American Association for the Study of Liver Diseases, October 27-31, 2000, Dallas, TX.
    Davis GL; Keeffe EB
    Rev Gastroenterol Disord; 2001; 1(1):42-7. PubMed ID: 12120119
    [No Abstract]   [Full Text] [Related]  

  • 17. Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha.
    Hirashima N; Mizokami M; Orito E; Koide T; Itazu I; Kumada K; Sakakibara K; Kano H; Lau JY
    J Gastroenterol Hepatol; 1996 Oct; 11(10):955-8. PubMed ID: 8912134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Ravi S; Axley P; Jones D; Kodali S; Simpson H; McGuire BM; Singal AK
    Gastroenterology; 2017 Mar; 152(4):911-912. PubMed ID: 28161225
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrence rate and prognosis of patients with hepatocellular carcinoma that developed after elimination of hepatitis C virus RNA by interferon therapy. A closed cohort study including matched control patients.
    Ikeda K; Kobayashi M; Saitoh S; Someya T; Hosaka T; Akuta N; Suzuki F; Tsubota A; Suzuki Y; Arase Y; Kumada H
    Oncology; 2003; 65(3):204-10. PubMed ID: 14657593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Shiomi S; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.